Xpovio (selinexor tablets) — Cigna
High-grade B-cell lymphoma
Initial criteria
- Patient age ≥ 18 years
- Patient has ONE of the following (i, ii, or iii): high-grade B-cell lymphoma; OR human immunodeficiency virus (HIV)-related B-cell lymphoma; OR post-transplant lymphoproliferative disorders
- Patient has tried at least two prior therapies
Approval duration
1 year